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Summary 
Background: Hand osteoarthritis (hand OA) mostly occurs in women around the time of menopause, but its relationship with sexual 
hormones remains a controversial issue. The eventual influence of hormone replacement herapy (HRT) on the incidence and progression 
of hand OA is still debated. 
Objective: To assess whether HRT influences the occurrence and disease activity of hand OA. 
Methods~patients: Epidemiological prospective cross-sectional study. Patients: Menopausal women, aged 50-75, consulting for painful hand 
OA, for another heumatic ondition with hand OA or controls (no disease of the upper limbs). Eligibility criteria: hand OA [American College 
Rheumatology (ACR) criteria] with X-ray evidence. Patients with 'painful' hand OA defined by a Dreiser's functional index score _>6 and pain 
on VAS >_35 mm. Study parameters: Demographics, personal histories and gynaecologic data for patients and controls including the 
administration of HRT (+) or not (-). For patients, description and symptom activity of hand OA. Statistics: Descriptive analysis in the studied 
population and in subsets taking into account treatment and disease activity factors. 
Resu/ts: 711 women were studied: 238 with 'painful' hand OA, 240 with 'quiescent' and 233 controls. Baseline characteristics were similar 
for patients and controls except for age (patients were older). HRT + patients were younger (-5 years) (,°<0.0001), slightly taller (P<0.0045) 
and more often cigarettes smokers (P<0.012) than HRT- patients. They did not differ in gynecologic haracteristics with the exception that 
the women in the HRT* group had been menopausal for a shorter period of time, probably because of their younger age. There were no 
differences between HRT + and HRT- patients, whatever the symptom activity, on the characteristics of hand OA: Dreiser's index scores 
were, respectively, 11.3+3.8 vs 12.3+4.5 in 'painful' patients, 3.6±2.5 vs 3.7+2.7 in 'quiescent' patients. Pain on VAS showed no difference 
between the two groups. 
Conclusion: Few differences were found between hand OA patients receiving HRT or not. HRT did not seem to influence the severity or the 
symptom activity of hand OA. Further prospective studies are required in order to evaluate the exact effect of HRT on hand OA. 
© 2000 OsteoArthritis Research Society International 
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Introduction 
Hand osteoarthritis (hand OA) commonly affects women, 
with peak onset around the time of the menopause. 1'2 The 
reasons for the predominance of hand OA with or without 
generalized osteoarthritis in women are not yet elucidated. 
Some authors have stated that hormonal factors could be 
responsible, 3-~ but the exact relationship between hand 
OA and sexual hormones is still controversial. 
Experimentally, estrogens have been found to protect 
male mice with increased susceptibility to OA but have 
worsened lesions in meniscectomized rabbits, while 
tamoxifen improved these lesions (in 2). Recently, it has 
been shown that biomechanical properties of the cartilage 
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were altered in ovariectomized sheep, but not in sheep 
treated by estradiol implants. 6
Clinically, works published in this field give conflicting 
results. Cauley et aL did not find any correlation between 
serum levels of various male and female sexual hormones 
and radiological severity of hand OA in 229 women. 7 
Schouten et al. did not find any increased risk in developing 
OA of the distal interphalangeal joints (DIP) in hysterect- 
omized women compared with naturally menopausal 
women. 8 He did observe, however, a statistically significant 
relationship between the occurrence of Heberden's nodes 
and both the age at menopause and the duration of the 
fertile period. Spector et aL reported an increased relative 
risk to develop OA of the knee and trapezometacarpal 
joints in hysterectomized women compared to age- 
matched controls. 9 
Studies concerning a protective effect of hormone 
replacement therapy (HRT) show contradictory results. 
Laroche et aL, in a case report, find a protective effect of 
estrogen/progesterone treatment. 1° Oliveria et al. did not 
find any protective action of estrogens on hand OA in 16 
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patients. 11 Zhang et al. does not report any protective ffect 
of estrogens on radiological lesions of hand OA assessed 
on X-rays taken at an 11-year interval in 407 women. 12 
Conversely, Spector et al. report a protective effect of 
current HRT (>12 months) with respect to knee [odds ratio 
(OR)=0.31, 95% confidence interval (CI): 0.11;0.93] and 
distal interphalangeal (DIP) OA (OR=0.48, 95% Ch 
0.17;1.42). 13 In their recent review, Felson and Nevitt have 
commented on the possible effect of estrogens on OA. TM 
We conducted this study to investigate the potential 
influence of HRT on the occurrence of hand QA and on its 
clinical severity. 
Methods and patients 
This was a prospective cross-sectional multicenter epi- 
demiologic study conducted in all areas of France by 250 
rheumatologists who recruited either women affected by 
hand OA or controls,, receiving HRT (HRT ÷) or not (HRT-). 
PATIENTS 
Each rheumatologist selected three patients as follows: 
women consulting for painful hand OA ('painful' hand OA 
group), women known to be affected by hand OA but 
consulting for another rheumatological condition ('quiesc- 
ent' hand OA) and women without hand OA ('control'). In 
order to insure a well-balanced recruitment of either HRT + 
or HRT- women, rheumatologists were divided into two 
groups: one selected exclusively women receiving HRT 
and the other only women without any hormonal therapy. 
ELIGIBILITY CRITERIA 
Consecutive menopausal patients (at least 6 months 
without menses), aged 50-75 years, consulting a rheuma- 
tologist. Hand OA patients needed to fulfill the American 
College of Rheumatology (ACR) criteria for the reporting of 
hand OA (Classification tree format) 15 and had to show 
X-ray features of hand OA on standard plain radiographs of 
both hands. In a previous work, differences have been 
observed with regard to OA history and clinical presentation 
between patients affected by 'painful' hand OA and patients 
affected by a 'quiescent' hand OA. 16 Therefore, each 
investigator was asked to select a 'painful' and a 'quiescent' 
patient. The cut-off was determined by a value of Dreiser's 
functional index (a validated 10-item investigator- 
administered questionnaire) 1~ (and see in this issue the 
paper by Dreiser) global score of 6 and a level of pain 
(during the previous 24 h) rated on a VAS at 35 mm. 
'Painful' hand OA patients were defined by: (1) a Dreiser's 
functional index score _>6 and (2) a spontaneous pain on 
VAS _>35 mm and 'quiescent' hand OA patients respectively 
by (1) a functional index score <6 and (2) pain on VAS 
<35mm. Excluded from both groups were patients 
presenting with a monoarticular post-traumatic hand OA. 
STUDY PARAMETERS 
For each case or control, the investigator collected the 
following information: (1) demographic data (age, height, 
weight), (2) medical history including cigarette smoking, 
history of hand OA in the family, the existence of radiologi- 
cally documented OA at other sites, and (3) gynecological 
data including the age at first menses, number of preg- 
nancies, age at menopause, time since menopause, exist- 
ence of HRT (past >6 months duration or current) and, for 
HRT ÷ patients the type of treatment administered from the 
various HRTs available today. 18 In addition, data for hand 
OA patients were collected including: values of Dreiser's 
functional index score, global spontaneous pain on VAS, 
handedness, delay since first symptoms, number of painful 
flares during the past 12 months, number of osteoarthritic 
joints, number of painful joints at the time of the visit, and 
number of joints with nodes (Heberden and/or Bouchard) 
reported on a sketch of both hands, and, if applicable, 
current professional occupation and sports activity. 
STATISTICAL ANALYSIS 
Patients were analysed regarding two factors: the exist- 
ence of HRT (HRT ÷ vs HRT- patients) and the sympto- 
matic activity of hand OA. Regarding hand OA activity, 
patients were divided into two groups according to the 
above mentioned criteria: 'painful' hand OA and 'quiescent' 
hand OA. All study parameters were analysed for the global 
sample and for each of the subgroups of patients. Statisti- 
cal comparisons were performed on these parameters 
between HRT ÷ and HRT- patients, between 'painful' hand 
OA and 'quiescent' hand OA patients and according to a 
two-way analysis (i.e. HRT ÷ vs HRT- 'painful' hand OA 
patients; HRT + vs HRT- 'quiescent' hand OA patients). 
The statistical tests were those usually used in such 
descriptive epidemiologic studies: Chi-square or Fisher's 
exact test (in case of small numbers) for the comparisons of 
the qualitative variables; two-way ANOVA taking into 
account both the treatment factor and the symptomatic 
activity of hand OA factor or one-way ANOVA for continu- 
ous variables. For pair-wise comparisons the Student t-test 
was performed. The results are presented for both groups 
of patients and for the controls, with regard to HRT use in 
the former. 
Results 
STUDIED POPULATION 
A total of 711 women were studied: 238 'painful' hand 
OA patients, 240 'quiescent' hand OA patients and 233 
controls. 
There were no differences in eligibility criteria between 
the two groups of hand OA patients: the majority fulfilled 
both the clinical ACR criteria and the X-ray features require- 
ment for the definition of hand OA (Table I). A.pproximately 
half of the patients or controls received HRT (current or 
past >6 months). 
DEMOGRAPHIC DATA 
The results appear in Table II. Mean age was compar- 
able in the 'painful' and 'quiescent' hand OA groups. On the 
other hand, controls were a little younger than hand OA 
patients, this difference being significant vs the 'quiescent' 
Iland OA group (adjusted mean age 61.6 versus 63.9 
years, P<0.001 ). The most important difference with regard 
to age was that HRT- patients, were five years older than 
HRT ÷ patients (65.2 years vs 60.3, P<0.0001). Maybe 
consequently, other statistically significant differences were 
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Table I 
Study groups--inc/usion criteria 
Characteristics Painful hand OA Quiescent hand OA Controls Total 
Number of patients (%) 238 (33.5) 240 (33.8) 233 (32.8) 711 
ACR criteria for hand OA definition 209 198 407 
X-ray <1 year 204 190 394 
Dreiser's index >_6 206 
Pain on VAS >_35 mm 206 
HRT current 91 (38.2) 85 (35.4) 91 (39.1) 267 (37.1) 
past 26 23 10 59 
none 121 (50.8) 132 (55.0) 132 (56.7) 385 
HRT=hormone replacement therapy. 
Table II 
Demographic characteristics in each group of patients 
Characteristic Painful hand OA Quiescent hand OA Controls 
HRT ÷ HRT- HRT ÷ HRT- HRT ÷ HRT- 
Number of patients 117 121 108 132 101 132 
Age (years) 60.4±6.0* 65.2±8.7 62.2±8.0* 65.8±7.9 58.4±5.9* 64.6+9.0 
Weight (kg) 62.1±9.5 62.4±10.0 62.4+9.3 64.6±10.2 62.1±9.3 63.8±11.3 
Height (cm) 160.8±5.81- 159.0±5.8 160.2±6.61 160.5±5.7 161.6±6.0t 159.3±5.1 
Cigarette smoking 18 (15.4%):1: 19 (15.7%) 21 (19.4%):1: 9 (6.8%) 23 (22.8%):I: 15 (11.4%) 
(current or past) 
*Statistically significant difference between HRT ÷ and HRT- patients: mean age higher in the HRT- group 
(P<0.0001). 
1.Statistically significant difference between HRT+ and HRT- patients: women receiving HRT were taller 
(P<0.0045). 
:l:Statistically significant difference between HRT + and HRT- patients: more cigarette smokers in women 
receiving HRT (19% vs 11.2%, P<0.012). 
HRT=Hormone replacement therapy. 
Table III 
Gynecologic characteristics in each group 
Characteristic Painful hand OA Quiescent hand OA Controls 
HRT + HRT- HRT ÷ HRT- HRT + HRT- 
Age at first menses (years) 
Age at menopause (years) 
Time since menopausis (months) 
Fertile period (years) 
Type of menopause: 
natural 101 (86.3%) 
surgical 16 
medical 0 
Number of pregnancies 2.2±1.3 
Type of HRT (%): 
estrogen 15 (13.6) 
combined estrogen and progesterone 61 (56) 
alternate estrogen and progesterone 35 (31.8) 
progesterone 3 (2.8) 
13.0±1.3 13.0+_1.2  13.0±1.5 13.0±1.5 13.0±1.3 13.1 ±1.5 
49.2±5.1 50.0±4.1 48.8±4.1 50.2±4.5 49.6±3.2 49.7±4.6 
125.5±84.6" 183.2±128.9 160.0±103.7" 182.4±107.7 110.3±82.8" 171.4±109.0 
36.1 ±5.4 36.9±4.1 35.8±4.3 37.2±4.7 36.6±3.3 36.6±4.8 
103 (88.8%) 95 (88.0%) 111 (86%) 103 (88.8%) 117 (90%) 
12 13 17 11 13 
1 0 1 1 0 
2.0+1.2 2.0±1.2 2.3±1.5 2.0±1.2 2.1 ±1.5 
16 (16.2) 10-(10.3) 
57 (57.6) 53 (54.6) 
26 (26.3) 33 (34) 
4 (4) 5 (5.2) 
*Statistically significant difference between HRT ÷ and HRT- patients: time since menopause was shorter in the HRT ÷ group than in the 
HRT- group. 
HRT=Hormone replacement therapy. 
observed between HRT ÷ and HRT- patients: the former 
were taller (P<O.0001), and smoked (or had smoked) 
cigarettes more frequently (19% vs 11%, P<0.012). 
GYNECOLOGIC CHARACTERISTICS 
Table III summarizes these data. 'Painful' and 'quiescent' 
patients and controls were comparable for all collected 
gynaecological parameters. Mean age at first menses was 
13 years, mean age at menopause was 50 years. Natural 
menopause occurred in 88% of the studied women, surgi- 
cal menopause accounting for the remaining 12%. The 
different types of HRT (estrogens, combined estrogen/ 
progesterone, alternating estrogen and progesterone, 
progesterone alone) were equally distributed in the three 
groups. The only difference observed between HRT ÷ and 
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Table IV 
Characteristics of hand OA and symptom severity in each group 
Characteristic Painful hand OA Quiescent hand OA 
HRT* HRT- HRT ÷ HRT- 
Family history of hand OA: yes (%) 
Other OA location: yes (%) 
Handedness: right (%) 
Past or current professional occupation 
Past or current sports activity 
Time since first pain in hand OA (months) 
Number of flares during the previous 12 months: 
1-4 
5-9 
_>10 
Number of osteoarthritic joints (clinical exam.) 
Number of painful joints 
Number of nodal joints 
Erosive hand OA: (%) 
Dreiser's functional index score (range: 0-30) 
Global spontaneous pain on VAS (mm) 
82 (70.1%) 85 (70.2%) 78 (72.2%) 79 (59.8%) 
85 (72.6%) 87 (71.9%) 79 (73.1%) 103 (78%) 
108 (96.4%) 117 (97.5%) 97 (94.2%) 113 (94.2%) 
90 (76.9%) 97 (80.2%) 84 (77.8%) 100 (75.8%) 
39 (34.8%) 22 (19.3%) 41 (39.8%) 31 (24.2%) 
75.6±66.1 83.8±80.8 81.4±78.0 82.8±70.0 
68 84 72 78 
20 20 3 4 
17" 11" 1 4 
3.9=4.5 3.5±3.6 4.0±4.2 3.7±3.0 
2.5±2.3* 3.7±3.3* 0.9±2.2 1.1 ±2.7 
3.9±4.0 5.2±4.0 3.8±4.0 3.3±3.5 
51 (43.6%) ° 45 (38.1%)" 15 (14.7%) 23 (17.7%) 
11.3±3.8 12.3±4.5 3.6±2.5 3.7 ±2.7 
55.8± 14.4 53.4± 15.6 16.4± 11.4 16.3± 12.9 
*Statistically significant difference between the painful hand OA patients group and the quiescent hand OA patients group: P<0.001. 
HRT=Hormone replacement herapy. 
HRT- patients concerned the time since menopause, 
which was shorter in HRT ÷ patients. This was not unex- 
pected, since these women were five years younger than 
HRT- patients. 
CHARACTERISTICS OF HAND OA 
Table IV provides the results. 96% of the patients were 
right-handed with no difference between symptom-related 
groups, nor between HRT ÷ and HRT- patients. Almost 
73% of the patients had OA at other sites (hip, knee, spine) 
with no differences observed between 'painful' and 'quiesc- 
ent' groups, nor between HRT ÷ and HRT- patients. There 
was a significant difference between controls and hand OA 
patients concerning the existence of a previous history of 
hand OA, 22% of controls vs 68% of hand OA patients 
reporting a familial history of hand OA. No difference in 
family history was found between the two groups of hand 
OA patients (P<0.266). In 80% of hand OA patients, it was 
the mother who had a history of hand OA. There was no 
difference with regard to a familial history of OA between 
HRT + and HRT- patients (P<0.100). 
No difference was observed between 'painful' and 
'quiescent' patients for the other characteristics of hand 
OA, with the exception of the percentage of erosive 
OA which was significantly higher in the 'painful' group 
(P<O.001). The other differences concerned the level of 
symptomatic activity which was obviously and by definition 
more severe in the 'painful' group (more patients experi- 
encing a greater number of flares during the previous year, 
higher values of Dreiser's index score and pain on VAS, 
higher number of painful joints). It can be noted that HRT ÷ 
patients had more past or current sports activity than HRT- 
patients regardless of symptom activity of hand OA. 
No other significant differences were observed between 
HRT ÷ and HRT- patients. The values of the Dreiser's index 
score were comparable: Dreiser's index scored respect- 
ively 11.3±3.8 vs 12.3±4.5 in 'painful' patients, 3.6±2.5 vs 
3.7±2.7 in quiescent patients, as were those of pain on 
VAS. The percentages of patients with erosive OA were 
higher in both HRT ÷ and HRT- 'painful' patients compared 
to 'quiescent' patients (P<0.001) and slightly higher in 
HRT ÷ vs HRT- 'painful' patients (44% vs 38%) but not in 
the overall HRT ÷ vs HRT- sample comparison. The mean 
numlSer of osteoarthritic joints, painful joints at visit and 
nodal joints were comparable in the 'painful' and 'quiescent' 
groups of patients. 
Discussion 
The present prospective cross-sectional epidemiological 
study was aimed at studying the characteristics of hand OA 
patients according to the administration of HRT or not, and 
at assessing whether or not HRT influenced the occurrence 
and severity of hand OA. One limitation of this work is that 
it was not a longitudinal study. 
In this study, we found no difference between HRT ÷ 
and HRT- patients with regard to the characteristics of 
hand OA. 
Patients were selected according to validated criteria for 
the reporting of hand OA is and divided into two groups with 
regard to symptom severity (Dreiser's index score and pain 
on VAS values). In addition, a control group was selected to 
ascertain whether some possible differences observed 
were related to HRT and not to the OA condition. It was 
decided to separate prior to the study the rheumatologists 
selecting women (case or control) receiving HRT or not. 
Half of the rheumatologists had to recruit HRT ÷ patients 
and control subjects while the other half had to recruit 
HRT- patients and control subjects. This was done in order 
to make sure there would be the same proportions of HRT ÷ 
or HRT- patients and to ensure a random selection of 
patients and avoid bias in the recruitment of HRT ÷ hand OA 
patients. However, selection bias might have occurred 
since this was a cross-sectional study and conducted in 
rheumatology practice. The results should be interpreted 
keeping in mind this distinction between participating 
rheumatologists. 
Except for age, patients and controls had comparable 
demographic and gynecological data. Family history of 
hand OA was more frequent in hand OA patients, which 
was expected. 
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There were important significant differences between 
'painful' and 'quiescent' hand OA patients concerning all 
the parameters of severity and symptom activity of hand 
OA, such as, by definition, the Dreiser's functional index 
score and pain on VAS values, the number of painful flares 
during the 12 previous months, the percentage of patients 
with erosive OA, the number of painful joints and the 
number of joints affected by OA. This means that the 
distinction of patients into 'painful' or 'quiescent' groups is 
clinically relevant, and should be considered in future 
epidemiological studies. 
When we compared HRT ÷ patients to HRT-, the only 
differences concerned some demographic and gynaeco- 
logical parameters: HRT ÷ patients were five years younger, 
taller, more often cigarette smokers, and had a shorter time 
since menopause at study entry. All these parameters may 
be related to the younger age, since nowadays HRT seems 
to be more systematically prescribed around the time of 
menopause. However, no difference was found between 
HRT ÷ and HRT- patients with regard to the characteristics 
of hand OA. The use of HRT was not associated with 
reduced severity or symptoms of hand OA in this study. The 
time since first symptoms, the number of flares during the 
past 12 months, the percentages of erosive OA, the level of 
pain (VAS) and the value of the Dreiser's functional index 
score were similar in hand OA patients whatever the 
hormone therapy and the symptom activity of hand OA. 
Therefore the existence of HRT (whatever the type of 
treatment) does not seem to have influenced the symptoms 
and structural course of hand OA in the studied population. 
A possible bias may have occurred in the recruitment of 
hand OA patients receiving HRT, resulting in the selection 
of a subset of HRT ÷ women. This bias seems unlikely, 
since HRT ÷ patients and controls were comparable for all 
parameters except age. 
Conclusion 
The results of this study do not support the hypothesis of 
a beneficial effect of HRT on prevention or stabilization of 
hand OA. This conflicts with results of some previous 
studies. We do not explain the absence of a beneficial 
influence of HRT on hand OA severity or symptom activity 
in this population. However, we recommend that future 
prospective longitudinal studies be conducted in order to 
assess clearly if HRT is of benefit to prevent or stabilize 
hand OA and if there are clinical parameters predictive of a 
good response to this treatment. 
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